1. Mottet N, Bellmunt J, Briers E, Bolla M, Bourke L, Cornford P, De Santis M, Henry A, Joniau S, Lam T, Mason MD, Van den Poel H, Van den Kwast TH, Rouvière O. Wiegel T (2017) EAU–ESTRO–SIOG guidelines on prostate cancer. European Association of Urology.
https://uroweb.org/guidelines/
. Accessed 28 Feb 2018
2. Witjes JAC, Compérat E, Cowan NC, Gakis G, Hernández V, Lebret T, Lorch A, van der Heijden AG, Ribal MJ, Guidelines Associates: Bruins M, Linares Espinós E, Rouanne M, Neuzillet Y, Veskimäe E (2017) Muscle Invasive and Metastatic Bladder Cancer. European Assocation of Urology.
https://uroweb.org/guidelines/
. Accessed 28 Feb 2018
3. Marks LB, Carrol PR, Dugan TC, Anscher MS (1995) The response of the urinary bladder, urethra and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31:1257–1280
4. Turner SL, Swindell R, Bowl N, Marrs J, Brookes B, Read G, Cowan RA (1997) Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys 39(2):355–360
5. O’Neill AGM, Jain S, Hounsell AR, O’Sullivan J (2016) Fiducial marker guided prostate radiotherapy: a review. Br J Radiol 89